{"id":701438,"date":"2026-01-15T18:51:47","date_gmt":"2026-01-15T23:51:47","guid":{"rendered":""},"modified":"2026-01-16T08:42:04","modified_gmt":"2026-01-16T13:42:04","slug":"president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing","status":"publish","type":"quick-take","link":"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/","title":{"rendered":"President Trump Proposes Codifying MFN Drug Pricing Deals But Key Details Are Missing"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">In his new \u201c<a href=\"https:\/\/www.whitehouse.gov\/fact-sheets\/2026\/01\/fact-sheet-president-donald-j-trump-calls-on-congress-to-enact-the-great-healthcare-plan\/\" target=\"_blank\" rel=\"noreferrer noopener\">Great Healthcare Plan,<\/a>\u201d President Trump has proposed to \u201ccodify\u201d the administration\u2019s most-favored-nation (MFN) drug pricing deals that have been agreed to by drug companies in recent months. These MFN agreements are based on the premise that the U.S. shouldn\u2019t pay higher prices for prescription drugs than the prices paid in other comparable nations, an idea that President Trump promoted in his first term through various proposals that were\u00a0<a href=\"https:\/\/www.kff.org\/medicare\/a-status-report-on-prescription-drug-policies-and-proposals-at-the-start-of-the-biden-administration\/\">ultimately not implemented<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In this second term, the Trump administration has&nbsp;<a href=\"https:\/\/www.kff.org\/from-drew-altman\/trump-has-no-health-plan-he-has-the-art-of-the-health-care-deal\/\">conducted dealmaking<\/a>&nbsp;behind the scenes to negotiate most favored nation pricing agreements with individual drug companies, bypassing more traditional regulatory or legislative approaches to secure these deals. The manufacturers have agreed to make certain products available to state Medicaid programs at most favored nation pricing, to introduce new medications at most favored nation pricing in the U.S., and to sell certain products directly to U.S. consumers at discounted prices. The manufacturers are also committing to increase their investment in U.S. manufacturing and in return they\u2019ll receive a 3-year reprieve from tariffs that would otherwise be imposed.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In general, the details of these agreements remain confidential, which means that very little is known publicly about what exactly has been agreed to. Although price discounts for specific drugs were highlighted at various\u00a0<a href=\"https:\/\/www.whitehouse.gov\/fact-sheets\/2025\/10\/fact-sheet-president-donald-j-trump-announces-second-deal-to-bring-most-favored-nation-pricing-to-american-patients\/\" target=\"_blank\" rel=\"noreferrer noopener\">White<\/a>\u00a0<a href=\"https:\/\/www.whitehouse.gov\/fact-sheets\/2025\/11\/fact-sheet-president-donald-j-trump-announces-major-developments-in-bringing-most-favored-nation-pricing-to-american-patients\/\" target=\"_blank\" rel=\"noreferrer noopener\">House<\/a>\u00a0<a href=\"https:\/\/www.whitehouse.gov\/fact-sheets\/2025\/12\/fact-sheet-president-donald-j-trump-announces-largest-developments-to-date-in-bringing-most-favored-nation-pricing-to-american-patients\/\" target=\"_blank\" rel=\"noreferrer noopener\">events<\/a>, the full scope of these deals \u2013 including which drugs are subject to these agreements, what specific pricing has been agreed to, and how MFN prices are determined \u2013 is largely unknown.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">As a result, it\u2019s difficult to understand what it would mean to \u201ccodify\u201d these deals. It\u2019s also not clear what the mechanism would be for extending these deals to all Americans. While codifying most-favored-nation drug pricing could be helpful for bringing more transparency to these arrangements and guaranteeing that drug companies will deliver on what they\u2019ve promised, policymakers would need substantially more information to turn these backroom voluntary deals into law.&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>While codifying most-favored-nation drug pricing could be helpful for bringing more transparency to these arrangements and guaranteeing that drug companies will deliver on what they\u2019ve promised, policymakers would need substantially more information to turn these backroom voluntary deals into law.<\/p>\n","protected":false},"author":155412937,"featured_media":701451,"template":"","meta":{"authors":[{"type":"foundation","id":67181,"name":"","_id":"3a12a103-1328-4b80-89e8-d51573a8564f"}],"exhibits":[],"jetpack_post_was_ever_published":false,"ep_exclude_from_search":false,"_classifai_error":"","_classifai_text_to_speech_error":"","search_keywords":"","footnotes":""},"categories":[1274092,1286878],"tags":[632330,34948,69739],"content-types":[579145484],"program":[],"series":[],"class_list":["post-701438","quick-take","type-quick-take","status-publish","has-post-thumbnail","hentry","category-health-costs","category-private-insurance","tag-access-to-care","tag-affordability","tag-prescription-drugs","content-types-quick-take"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.9 (Yoast SEO v25.9) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>President Trump Proposes Codifying MFN Drug Pricing Deals But Key Details Are Missing | KFF Quick Takes<\/title>\n<meta name=\"description\" content=\"While codifying most-favored-nation drug pricing could be helpful for bringing more transparency to these arrangements and guaranteeing that drug companies will deliver on what they\u2019ve promised, policymakers would need substantially more information to turn these backroom voluntary deals into law.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"President Trump Proposes Codifying MFN Drug Pricing Deals But Key Details Are Missing\" \/>\n<meta property=\"og:description\" content=\"While codifying most-favored-nation drug pricing could be helpful for bringing more transparency to these arrangements and guaranteeing that drug companies will deliver on what they\u2019ve promised, policymakers would need substantially more information to turn these backroom voluntary deals into law.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/\" \/>\n<meta property=\"og:site_name\" content=\"KFF\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-16T13:42:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.kff.org\/wp-content\/uploads\/sites\/7\/2026\/01\/260116_QuickTakes_Juliette-Cubanski_Website.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/\",\"url\":\"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/\",\"name\":\"President Trump Proposes Codifying MFN Drug Pricing Deals But Key Details Are Missing | KFF Quick Takes\",\"isPartOf\":{\"@id\":\"https:\/\/www.kff.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.kff.org\/wp-content\/uploads\/sites\/7\/2026\/01\/260116_QuickTakes_Juliette-Cubanski_Website.png\",\"datePublished\":\"2026-01-15T23:51:47+00:00\",\"dateModified\":\"2026-01-16T13:42:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/#primaryimage\",\"url\":\"https:\/\/www.kff.org\/wp-content\/uploads\/sites\/7\/2026\/01\/260116_QuickTakes_Juliette-Cubanski_Website.png\",\"contentUrl\":\"https:\/\/www.kff.org\/wp-content\/uploads\/sites\/7\/2026\/01\/260116_QuickTakes_Juliette-Cubanski_Website.png\",\"width\":1920,\"height\":1080},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.kff.org\/#website\",\"url\":\"https:\/\/www.kff.org\/\",\"name\":\"KFF - The independent source for health policy research, polling, and news\",\"description\":\"The independent source for health policy research, polling, and news\",\"publisher\":{\"@id\":\"https:\/\/www.kff.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.kff.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.kff.org\/#organization\",\"name\":\"KFF\",\"url\":\"https:\/\/www.kff.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.kff.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.kff.org\/wp-content\/uploads\/sites\/7\/2025\/04\/KFF_Black.png\",\"contentUrl\":\"https:\/\/www.kff.org\/wp-content\/uploads\/sites\/7\/2025\/04\/KFF_Black.png\",\"width\":3186,\"height\":1296,\"caption\":\"KFF\"},\"image\":{\"@id\":\"https:\/\/www.kff.org\/#\/schema\/logo\/image\/\"}},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.kff.org\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Quick Takes\",\"item\":\"https:\/\/www.kff.org\/quick-take\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"President Trump Proposes Codifying MFN Drug Pricing Deals But Key Details Are Missing\",\"item\":\"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"President Trump Proposes Codifying MFN Drug Pricing Deals But Key Details Are Missing\"}]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"President Trump Proposes Codifying MFN Drug Pricing Deals But Key Details Are Missing | KFF Quick Takes","description":"While codifying most-favored-nation drug pricing could be helpful for bringing more transparency to these arrangements and guaranteeing that drug companies will deliver on what they\u2019ve promised, policymakers would need substantially more information to turn these backroom voluntary deals into law.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/","og_locale":"en_US","og_type":"article","og_title":"President Trump Proposes Codifying MFN Drug Pricing Deals But Key Details Are Missing","og_description":"While codifying most-favored-nation drug pricing could be helpful for bringing more transparency to these arrangements and guaranteeing that drug companies will deliver on what they\u2019ve promised, policymakers would need substantially more information to turn these backroom voluntary deals into law.","og_url":"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/","og_site_name":"KFF","article_modified_time":"2026-01-16T13:42:04+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.kff.org\/wp-content\/uploads\/sites\/7\/2026\/01\/260116_QuickTakes_Juliette-Cubanski_Website.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/","url":"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/","name":"President Trump Proposes Codifying MFN Drug Pricing Deals But Key Details Are Missing | KFF Quick Takes","isPartOf":{"@id":"https:\/\/www.kff.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/#primaryimage"},"image":{"@id":"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/#primaryimage"},"thumbnailUrl":"https:\/\/www.kff.org\/wp-content\/uploads\/sites\/7\/2026\/01\/260116_QuickTakes_Juliette-Cubanski_Website.png","datePublished":"2026-01-15T23:51:47+00:00","dateModified":"2026-01-16T13:42:04+00:00","breadcrumb":{"@id":"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/#primaryimage","url":"https:\/\/www.kff.org\/wp-content\/uploads\/sites\/7\/2026\/01\/260116_QuickTakes_Juliette-Cubanski_Website.png","contentUrl":"https:\/\/www.kff.org\/wp-content\/uploads\/sites\/7\/2026\/01\/260116_QuickTakes_Juliette-Cubanski_Website.png","width":1920,"height":1080},{"@type":"WebSite","@id":"https:\/\/www.kff.org\/#website","url":"https:\/\/www.kff.org\/","name":"KFF - The independent source for health policy research, polling, and news","description":"The independent source for health policy research, polling, and news","publisher":{"@id":"https:\/\/www.kff.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.kff.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.kff.org\/#organization","name":"KFF","url":"https:\/\/www.kff.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.kff.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.kff.org\/wp-content\/uploads\/sites\/7\/2025\/04\/KFF_Black.png","contentUrl":"https:\/\/www.kff.org\/wp-content\/uploads\/sites\/7\/2025\/04\/KFF_Black.png","width":3186,"height":1296,"caption":"KFF"},"image":{"@id":"https:\/\/www.kff.org\/#\/schema\/logo\/image\/"}},{"@type":"BreadcrumbList","@id":"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.kff.org"},{"@type":"ListItem","position":2,"name":"Quick Takes","item":"https:\/\/www.kff.org\/quick-take\/"},{"@type":"ListItem","position":3,"name":"President Trump Proposes Codifying MFN Drug Pricing Deals But Key Details Are Missing","item":"https:\/\/www.kff.org\/quick-take\/president-trump-proposes-codifying-mfn-drug-pricing-deals-but-key-details-are-missing\/"},{"@type":"ListItem","position":4,"name":"President Trump Proposes Codifying MFN Drug Pricing Deals But Key Details Are Missing"}]}]}},"jetpack_sharing_enabled":true,"editor_excerpt":"While codifying most-favored-nation drug pricing could be helpful for bringing more transparency to these arrangements and guaranteeing that drug companies will deliver on what they\u2019ve promised, policymakers would need substantially more information to turn these backroom voluntary deals into law.","publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"KFF","distributor_original_site_url":"https:\/\/www.kff.org","push-errors":false,"_links":{"self":[{"href":"https:\/\/www.kff.org\/wp-json\/wp\/v2\/quick-take\/701438","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.kff.org\/wp-json\/wp\/v2\/quick-take"}],"about":[{"href":"https:\/\/www.kff.org\/wp-json\/wp\/v2\/types\/quick-take"}],"author":[{"embeddable":true,"href":"https:\/\/www.kff.org\/wp-json\/wp\/v2\/users\/155412937"}],"version-history":[{"count":6,"href":"https:\/\/www.kff.org\/wp-json\/wp\/v2\/quick-take\/701438\/revisions"}],"predecessor-version":[{"id":701453,"href":"https:\/\/www.kff.org\/wp-json\/wp\/v2\/quick-take\/701438\/revisions\/701453"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.kff.org\/wp-json\/wp\/v2\/media\/701451"}],"wp:attachment":[{"href":"https:\/\/www.kff.org\/wp-json\/wp\/v2\/media?parent=701438"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.kff.org\/wp-json\/wp\/v2\/categories?post=701438"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.kff.org\/wp-json\/wp\/v2\/tags?post=701438"},{"taxonomy":"content-types","embeddable":true,"href":"https:\/\/www.kff.org\/wp-json\/wp\/v2\/content-types?post=701438"},{"taxonomy":"program","embeddable":true,"href":"https:\/\/www.kff.org\/wp-json\/wp\/v2\/program?post=701438"},{"taxonomy":"series","embeddable":true,"href":"https:\/\/www.kff.org\/wp-json\/wp\/v2\/series?post=701438"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}